At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 33 enrolled
Drug / intervention
Avagard +1 moredrug
Likely dose
Avagard 6 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Two-week Crossover Evaluation of Two Hand Antiseptic Products on Skin Condition in Healthy Human Subjects
In Brief
A Phase 4 clinical trial evaluating Avagard and Purell Surgical Scrub for Healthy. Completed, enrolled 33 participants.
Detailed Summary
Evaluate the effect of two hand antiseptic products on hand skin conditions of healthy volunteers.
Study Details
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2008
Primary CompletionApr 2008
Study CompletionJul 2008
First PostedAug 2008
TodayJul 2026
First PostedAug 8, 2008
Enrollment StartMar 1, 2008
Primary CompletionApr 1, 2008
Study CompletionJul 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.9 years ago
Interventions
Avagarddrug
Topical solution, 6 mL, 6 applications/day for 14 days.
Purell Surgical Scrubdrug
Topical solution, 4 mL, 6 applications/day for 14 days.